Diadem Digital Solutions LLC

5 articles with Diadem Digital Solutions LLC

• 

  Exciting Advancements in Multiple Myeloma, Asthma and Alzheimer’s

  5/16/2022

  Sanofi, AstraZeneca, Avillion and Diadem recently announced clinical results, providing positive news for patients with multiple myeloma, asthma and Alzheimer’s disease.
• 

  It's Full Speed Ahead for Many Alzheimer's Players Following CMS Decision

  4/11/2022

  Following the decision to limit the coverage of Biogen’s controversial Alzheimer’s drug Aduhelm, the Alzheimer’s community is now waiting for other companies to deliver new therapies.
• 

  Biomarkers: a Beacon of Hope for the Future of Alzheimer's

  3/22/2022

  Esai, Biogen, Diadem and ProMis all presented their findings on biomarker research at this year's International Conference on Alzheimer's and Parkinson's Diseases.

• Diadem Presents Clinical Validation Interim Data Confirming Its AlzoSure® Prognostic Biomarker Test Accurately Predicts Progression to Alzheimer's Disease

  5/18/2021

  Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease, announced top-line interim results from a global clinical validation study of its AlzoSure® Predict prognostic biomarker test, which can accurately predict progression to Alzheimer's disease years before symptoms appear.

• Companies Like Diadem Digital Solutions LLC Turn To Medical Devices To Relieve Aching Budgets

  3/8/2010